posoleucel
Generic: ALVR105·Code: ALVR105
posoleucel: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | Phase 3 |
Get deeper analysis on posoleucel
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis